Two sickle cell disease researchers will share a $3 million Breakthrough Prize for discoveries that changed the treatment ...

Etavopivat improved hemoglobin levels and reduced pain crises in a Phase 3 sickle cell disease trial, supporting potential ...

Newly diagnosed with DVT and a pulmonary embolism, columnist Michelle Harlan finds herself in an unfamiliar relationship with ...

Having a remote job has been a game-changer for me as someone with sickle cell disease. I’m better able to manage my health — no rushed mornings, cold commutes, or physical strain. I can plan my day ...

People with sickle cell disease in Africa are less likely to use common treatments and may report lower burden, a global ...

Dunstan Nicol-Wilson is a clinical project manager from South East London, United Kingdom. Dunstan has his master’s in public health with a global health focus. Dunstan was diagnosed with the ...

Bias in sickle cell care may be tied to opioid stigma, with patients more often described negatively in medical records, a ...

The isolation of chronic disease isn't just about being physically alone; it's also emotional and social, says columnist ...

Agios Pharmaceuticals is planning to file an application with the U.S. Food and Drug Administration (FDA) in the coming months that will seek accelerated approval of its oral therapy mitapivat for ...

Through a project aimed at building empathy and understanding among clinicians about sickle cell disease (SCD)-related pain episodes, a team of nurses in Chicago has helped standardize emergency care ...

A sickle cell crisis isn’t a polite guest, and it often arrives unannounced. Over the years, I’ve learned that my crises either come on suddenly or build gradually, with subtle clues or a red alert.

A bipartisan team of U.S. senators has introduced legislation to renew funding for a national initiative that connects people with blood disorders such as sickle cell disease (SCD) with unrelated ...